Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjögren's syndrome

Rheumatology (Oxford). 2023 Sep 1;62(9):e258-e259. doi: 10.1093/rheumatology/kead115.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Cholesterol Ester Transfer Proteins*
  • Humans
  • Lipoproteins, HDL / metabolism
  • Sjogren's Syndrome*

Substances

  • Cholesterol Ester Transfer Proteins
  • Lipoproteins, HDL